Skip to main content
Midas Edge

Acadia Healthcare Company, Inc.

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

ACHC$38.64+0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Equity (Unaudited)

Condensed Consolidated Statements of Equity

(In thousands)

Common Stock · AdditionalPaid-in · Retained
Shares · Amount · Capital · Earnings · Total
Balance at December 31, 202391,264$913$2,649,340$131,721$2,781,974
Common stock issued under stock incentive plans31034,099—4,102
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(5,115)—(5,115)
Equity-based compensation expense——8,678—8,678
Net income attributable to Acadia Healthcare Company, Inc.———76,38376,383
Balance at March 31, 202491,5749162,657,002208,1042,866,022
Common stock issued under stock incentive plans10711,477—1,478
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(2,133)—(2,133)
Equity-based compensation expense——8,869—8,869
Net income attributable to Acadia Healthcare Company, Inc.———78,48278,482
Balance at June 30, 202491,6819172,665,215286,5862,952,718
Common stock issued under stock incentive plans7611,608—1,609
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(765)—(765)
Equity-based compensation expense——9,467—9,467
Other——357357
Net income attributable to Acadia Healthcare Company, Inc.———68,13268,132
Balance at September 30, 202491,7579182,675,882354,7183,031,518
Common stock issued under stock incentive plans18—21—21
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(538)—(538)
Equity-based compensation expense——10,099—10,099
Net income attributable to Acadia Healthcare Company, Inc.———32,61532,615
Balance at December 31, 202491,7759182,685,464387,3333,073,715
Common stock issued under stock incentive plans2172(2)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(1,936)—(1,936)
Repurchase of common stock, including excise tax(1,603)(16)—(47,256)(47,272)
Equity-based compensation expense——8,677—8,677
Net income attributable to Acadia Healthcare Company, Inc.———8,3748,374
Balance at March 31, 202590,3899042,692,203348,4513,041,558
Common stock issued under stock incentive plans1091(1)——
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(1,780)—(1,780)
Repurchase of common stock, including excise tax(104)(1)—(3,159)(3,160)
Equity-based compensation expense——10,549—10,549
Other——692—692
Net income attributable to Acadia Healthcare Company, Inc.———30,12730,127
Balance at June 30, 202590,3949042,701,663375,4193,077,986
Common stock issued under stock incentive plans38————
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises——(237)—(237)
Repurchase of common stock, including excise tax———99
Equity-based compensation expense——6,031—6,031
Other——262—262
Net income attributable to Acadia Healthcare Company, Inc.———36,24636,246
Balance at September 30, 202590,432$904$2,707,719$411,674$3,120,297
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.